CBD Global Sciences Revenue
What is the Revenue of CBD Global Sciences?
The Revenue of CBD Global Sciences Inc. is $703.855k
What is the definition of Revenue?
Revenue is the income that a business has from its normal business activities, usually from the sale of goods and services to customers.
ttm (trailing twelve months)
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Revenue of companies in the Health Care sector on OTC compared to CBD Global Sciences
What does CBD Global Sciences do?
CBD Global Sciences Inc. engages in cannabidiol (CBD) farming, processing, and product manufacturing business. It offers provides biomass, CBD oil, and CBD oil products under the Aethics, CannaOil, and Strasburg Pharms brand names. The company was incorporated in 2018 and is headquartered in Lakewood, Colorado.
Companies with revenue similar to CBD Global Sciences
- Elsight has Revenue of $685.708k
- CruzSur has Revenue of $690.000k
- Generex Biotechnology has Revenue of $692.762k
- Tayo Rolls has Revenue of ₨700.000k
- Hexagon Materials has Revenue of AUD$703.000k
- EastWest Bioscience has Revenue of CAD$703.102k
- CBD Global Sciences has Revenue of $703.855k
- Sabre Resources has Revenue of AUD$704.000k
- DXI has Revenue of CAD$710.000k
- Sequana Medical NV has Revenue of €712.000k
- Strata-X has Revenue of AUD$716.000k
- Strata-X has Revenue of AUD$716.000k
- Real has Revenue of AUD$716.000k